Skip to main content
. 2021 Jul 1;11:638619. doi: 10.3389/fonc.2021.638619

Figure 2.

Figure 2

Post-recurrence survival in breast cancer patients according to (A) ER conversion and (B) PR conversion. ER, estrogen receptor; PR, progesterone receptor.